4.8 Editorial Material

Prediction algorithms: pitfalls in interpreting genetic variants of autosomal dominant monogenic diabetes

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 130, 期 1, 页码 14-16

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI133516

关键词

-

资金

  1. National Institute for Health Research Exeter Clinical Research Facility
  2. Wellcome Trust [110082/Z/15/Z]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Hyperinsulinemic Hypoglycemia Diagnosed in Childhood Can Be Monogenic

Jasmin J. Hopkins, Alexandra J. Childs, Jayne Al Houghton, Thomas Hewat, Navoda Atapattu, Matthew B. Johnson, Kashyap A. Patel, Thomas W. Laver, Sarah E. Flanagan

Summary: This study suggests that monogenic mutations are an important cause of hyperinsulinism presenting outside of infancy. Genetic testing should be considered in children with persistent hyperinsulinism, regardless of age at diagnosis.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Genetics & Heredity

Recurrent 17q12 microduplications contribute to renal disease but not diabetes

Stuart Cannon, Rhian Clissold, Kittiya Sukcharoen, Marcus Tuke, Gareth Hawkes, Robin N. Beaumont, Andrew R. Wood, Mark Gilchrist, Andrew T. Hattersley, Richard A. Oram, Kashyap Patel, Caroline Wright, Michael N. Weedon

Summary: 17q12 microdeletion and microduplication syndromes are complex disorders with overlapping phenotypes, including diabetes, renal disease, and neurocognitive traits.

JOURNAL OF MEDICAL GENETICS (2023)

Article Endocrinology & Metabolism

Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes

Lilianna Bakinowska, Tanwi Vartak, Thato Phuthego, Michelle Taylor, Kyla Chandler, Samual T. Jerram, Steven Williams, Marc Feldmann, Desmond G. Johnson, Kashyap A. Patel, Alistair J. K. Williams, Anna E. Long, R. David Leslie, Kathleen M. Gillespie

Summary: Proteomic profiling identified significant differences in exocrine enzyme levels in twins with type 1 diabetes. Validation experiments showed lower trypsin(ogen) levels in twins with diabetes. These findings highlight the important role of altered exocrine function in the development of type 1 diabetes.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes

Nicholas J. Thomas, Helen C. Walkey, Akaal Kaur, Shivani Misra, Nick S. Oliver, Kevin Colclough, Michael N. Weedon, Desmond G. Johnston, Andrew T. Hattersley, Kashyap A. Patel

Summary: By assessing the genetic risk of type 1 diabetes in autoantibody-negative and -positive individuals, the study found that autoantibody-negative adults with clinician-diagnosed type 1 diabetes had a lower genetic risk compared to autoantibody-positive adults but higher risk compared to type 2 diabetes. The presence of non-autoimmune diabetes was identified as the likely explanation for the lower rate of autoantibody positivity in adult-onset type 1 diabetes.

DIABETOLOGIA (2023)

Article Medicine, Research & Experimental

Infancy-onset diabetes caused by de-regulated AMPylation of the human endoplasmic reticulum chaperone BiP

Luke A. Perera, Andrew T. Hattersley, Heather P. Harding, Matthew N. Wakeling, Sarah E. Flanagan, Ibrahim Mohsina, Jamal Raza, Alice Gardham, David Ron, Elisa De Franco

Summary: Mutation in the FICD gene leads to dysfunction of the endoplasmic reticulum, resulting in cell loss and diabetes mellitus. The study suggests that regulating the activity of FICD may provide therapeutic benefits for treating related diseases.

EMBO MOLECULAR MEDICINE (2023)

Article Health Care Sciences & Services

Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches

Nicholas J. Thomas, Andrew McGovern, Katherine G. Young, Seth A. Sharp, Michael N. Weedon, Andrew T. Hattersley, John Dennis, Angus G. Jones

Summary: This study aimed to compare the performance of different approaches for classifying insulin-treated diabetes without measured classification biomarkers. The results showed that combining early insulin requirement with a T1D probability model and interview-reported diabetes type achieved the highest accuracy.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Article Immunology

FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome

Rebecca C. Wyatt, Sven Olek, Elisa De Franco, Bjoern Samans, Kashyap Patel, Jayne Houghton, Steffi Walter, Janika Schulze, Rosa Bacchetta, Andrew T. Hattersley, Sarah E. Flanagan, Matthew B. Johnson

Summary: By studying a large cohort of patients diagnosed with IPEX and using TSDR analysis, it was found that diagnosing IPEX at presentation with isolated diabetes can effectively monitor disease progression and predict the course of the disease. This method can aid in the classification and diagnosis of FOXP3 variants and allow for immune modulatory treatment to be initiated before the onset of severe enteropathy.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Beverley M. Shields, Catherine D. Angwin, Maggie H. Shepherd, Nicky Britten, Angus G. Jones, Naveed Sattar, Rury Holman, Ewan R. Pearson, Andrew T. Hattersley

Summary: Patient preference plays a crucial role in medication selection for chronic medical conditions like type 2 diabetes. Balancing potential efficacy and side effects, patient preference can inform treatment decisions based on personal experience with alternative medications. A recent study on type 2 diabetes patients compared three different glucose-lowering drugs and found that allocating therapy based on individual drug preference resulted in better glycemic control and fewer side effects compared to prescribing the overall most preferred drug.

NATURE MEDICINE (2023)

Article Biochemistry & Molecular Biology

Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Beverley M. M. Shields, John M. M. Dennis, Catherine D. D. Angwin, Fiona Warren, William E. E. Henley, Andrew J. J. Farmer, Naveed Sattar, Rury R. R. Holman, Angus G. G. Jones, Ewan R. R. Pearson, Andrew T. T. Hattersley

Summary: Precision medicine in type 2 diabetes aims to treat patients based on their clinical characteristics. This study examines the differential drug response in relation to body mass index (BMI) and estimated glomerular filtration rate (eGFR). The findings suggest that in obese patients, thiazolidinediones may be more effective in lowering glucose levels compared to DPP4 inhibitors, while in patients with eGFR of 60-90 ml/min/1.73 m², DPP4 inhibitors may be more effective than SGLT2 inhibitors in lowering glucose levels.

NATURE MEDICINE (2023)

Article Cell Biology

The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits

Maria C. Costanzo, Marcin von Grotthuss, Jeffrey Massung, Dongkeun Jang, Lizz Caulkins, Ryan Koesterer, Clint Gilbert, Ryan P. Welch, Parul Kudtarkar, Quy Hoang, Andrew P. Boughton, Preeti Singh, Ying Sun, Marc Duby, Annie Moriondo, Trang Nguyen, Patrick Smadbeck, Benjamin R. Alexander, MacKenzie Brandes, Mary Carmichael, Peter Dornbos, Todd Green, Kenneth C. Huellas-Bruskiewicz, Yue Ji, Alexandria Kluge, Aoife C. McMahon, Josep M. Mercader, Oliver Ruebenacker, Sebanti Sengupta, Dylan Spalding, Daniel Taliun, Philip Smith, Melissa K. Thomas, Beena Akolkar, M. Julia Brosnan, Andriy Cherkas, Audrey Y. Chu, Eric B. Fauman, Caroline S. Fox, Tania Nayak Kamphaus, Melissa R. Miller, Lynette Nguyen, Afshin Parsa, Dermot F. Reilly, Hartmut Ruetten, David Wholley, Norann A. Zaghloul, Goncalo R. Abecasis, David Altshuler, Thomas M. Keane, Mark I. McCarthy, Kyle J. Gaulton, Jose C. Florez, Michael Boehnke, Noel P. Burtt, Jason Flannick

Summary: This study aims to make the Type 2 Diabetes Knowledge Portal (T2DKP) more accessible and useful to both new and existing users. It evaluates the comprehensiveness of T2DKP by comparing its datasets with other repositories, guides researchers unfamiliar with human genetic data on how to interpret and use the data through T2DKP, and discusses the importance of democratizing access to complex disease genetic results.

CELL METABOLISM (2023)

Correction Endocrinology & Metabolism

The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis (vol 66, pg 300, 2023)

Katherine G. Young, Andrew P. McGovern, Ines Barroso, Andrew T. Hattersley, Angus G. Jones, Beverley M. Shields, Nicholas J. Thomas, John M. Dennis

DIABETOLOGIA (2023)

Editorial Material Medical Laboratory Technology

Laboratory Guidelines Are Needed for Diagnostic Genetic Testing for Monogenic Diabetes

Andrew T. Hattersley

CLINICAL CHEMISTRY (2023)

Article Endocrinology & Metabolism

Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing

Alice E. Hughes, Jayne A. L. Houghton, Benjamin Bunce, Ali J. Chakera, Gill Spyer, Maggie H. Shepherd, Sarah E. Flanagan, Andrew T. Hattersley

Summary: In pregnancies with maternal glucokinase-MODY (GCK-MODY), fetal growth is determined by fetal genotype. A non-invasive prenatal testing of fetal GCK genotype (NIPT-GCK) using cell-free DNA in maternal blood has been developed. This study compared the diagnostic accuracy of NIPT-GCK with ultrasound and assessed the feasibility of using NIPT-GCK for pregnancy management.

DIABETOLOGIA (2023)

Article Endocrinology & Metabolism

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Brown, Timothy J. McDonald, Lin Li, Shuaicheng Wang, Mun-Gwan Hong, Sapna Sharma, Neil R. Robertson, Anubha Mahajan, Xuan Wang, Mark Walker, Stephen Gough, Leen M. 't Hart, Kaixin Zhou, Ian Forgie, Hartmut Ruetten, Imre Pavo, Pallav Bhatnagar, Angus G. Jones, Ewan R. Pearson, for the D. I. R. E. C. T. consortium DIRECT consortium

Summary: This study identified genetic variants associated with the response to GLP-1 receptor agonist treatment in patients with type 2 diabetes, which provides valuable insights for clinical decision making and personalized medicine.

LANCET DIABETES & ENDOCRINOLOGY (2023)

暂无数据